Summary:
A 59-year-old female with an unresectable, large pancreatic tumor (10.0 × 8.0 cm2 on CT scan) underwent nonmyeloablative allogeneic peripheral-blood stem-cell transplantation from her HLA-identical sibling. Pronounced tumor regression and relief from pain without acute graft-versus-host disease (GVHD) were observed following transplantation. The patient is surviving (more than 300 days) after transplantation, with extensive chronic GVHD, and has tumor regression with an 80% reduction in tumor size. The observed clinical course may suggest a graft-versus-tumor effect on the pancreatic tumor following allogeneic stem-cell transplantation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weiden PL, Flournoy N, Thomas ED et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068–1073.
Eibl B, Schwaighofer H, Nachbaur D et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood 1996; 88: 1501–1508.
Ueno NT, Rondon G, Mirza NQ et al. Allogeneic peri-pheral-blood progenitor cell transplantation for poor-risk patients with metastatic breast cancer. J Clin Oncol 1998; 16: 986–993.
Childs R, Clave E, Tisdale J et al. Successful treatment of metastatic renal cell carcinoma with nonmyeloablative allogeneic peripheral-blood progenitor-cell transplantation: evidence for a graft-versus-tumor effect. J Clin Oncol 1999; 17: 2044–2049.
Childs R, Chernoff A, Contentin N et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750–758.
Zetterquist H, Hentschke P, Thoerne A et al. A graft-versus-colonic cancer effect of allogeneic stem cell transplantation. Bone Marrow transplant 2001; 28: 1161–1166.
Parker SL, Tong T, Bolden S et al. Cancer statistics. Cancer 1996; 46: 5–27.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Omuro, Y., Matsumoto, G., Sasaki, T. et al. Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. Bone Marrow Transplant 31, 943–945 (2003). https://doi.org/10.1038/sj.bmt.1703932
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703932
Keywords
This article is cited by
-
Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study
BMC Cancer (2014)
-
Effect of bone marrow mesenchymal stem cells on hepatocellular carcinoma in microcirculation
Tumor Biology (2013)
-
Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
Nature Clinical Practice Oncology (2008)
-
Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese survey
Bone Marrow Transplantation (2008)
-
Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Cell Research (2008)